<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33693641</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>144</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>17</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Aberrant cytoplasmic intron retention is a blueprint for RNA binding protein mislocalization in VCP-related amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1985</StartPage><EndPage>1993</EndPage><MedlinePgn>1985-1993</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awab078</ELocationID><Abstract><AbstractText>We recently described aberrantly increased cytoplasmic SFPQ intron-retaining transcripts (IRTs) and concurrent SFPQ protein mislocalization as new hallmarks of amyotrophic lateral sclerosis (ALS). However, the generalizability and potential roles of cytoplasmic IRTs in health and disease remain unclear. Here, using time-resolved deep sequencing of nuclear and cytoplasmic fractions of human induced pluripotent stem cells undergoing motor neurogenesis, we reveal that ALS-causing VCP gene mutations lead to compartment-specific aberrant accumulation of IRTs. Specifically, we identify &gt;100 IRTs with increased cytoplasmic abundance in ALS samples. Furthermore, these aberrant cytoplasmic IRTs possess sequence-specific attributes and differential predicted binding affinity to RNA binding proteins. Remarkably, TDP-43, SFPQ and FUS-RNA binding proteins known for nuclear-to-cytoplasmic mislocalization in ALS-abundantly and specifically bind to this aberrant cytoplasmic pool of IRTs. Our data are therefore consistent with a novel role for cytoplasmic IRTs in regulating compartment-specific protein abundance. This study provides new molecular insight into potential pathomechanisms underlying ALS and highlights aberrant cytoplasmic IRTs as potential therapeutic targets.</AbstractText><CopyrightInformation>&#xa9; The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tyzack</LastName><ForeName>Giulia E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neeves</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crerar</LastName><ForeName>Hamish</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziff</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taha</LastName><ForeName>Doaa M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zoology Department, Faculty of Science, Alexandria University, Alexandria 21511, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luisier</LastName><ForeName>Rapha&#xeb;lle</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Genomics and Health Informatics Group, Idiap Research Institute, CH - 1920 Martigny, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luscombe</LastName><ForeName>Nicholas M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Genetics Institute, University College London, London, WC1E 6BT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Okinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patani</LastName><ForeName>Rickie</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3825-7675</Identifier><AffiliationInfo><Affiliation>Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FC010110</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S006591/1</GrantID><Agency>MRC Senior Clinical Fellowship</Agency><Country/></Grant><Grant><GrantID>FC010110</GrantID><Acronym>CRUK_</Acronym><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L016311/1</GrantID><Agency>MRC eMedLab Medical Bioinformatics Infrastructure Award</Agency><Country/></Grant><Grant><GrantID>FC010110</GrantID><Agency>UK Medical Research Council</Agency><Country/></Grant><Grant><GrantID>103760/Z/14/Z</GrantID><Agency>Wellcome Trust funding</Agency><Country/></Grant><Grant><GrantID>MR/M02492X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S006591/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="C000614178">VCP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="D000074405">Valosin Containing Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Brain Commun. 2021 Aug 06;3(3):fcab166</RefSource><PMID Version="1">34396115</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007438" MajorTopicYN="Y">Introns</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074405" MajorTopicYN="N">Valosin Containing Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cytoplasmic intron retention</Keyword><Keyword MajorTopicYN="N">human stem cell model</Keyword><Keyword MajorTopicYN="N">nuclear/cytoplasmic fractionation</Keyword><Keyword MajorTopicYN="N">protein mislocalization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33693641</ArticleId><ArticleId IdType="pmc">PMC8370440</ArticleId><ArticleId IdType="doi">10.1093/brain/awab078</ArticleId><ArticleId IdType="pii">6164957</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yap K, Lim ZQ, Khandelia P, Friedman B, Makeyev EV.. Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention. Genes Dev. 2012;26:1209&#x2013;1223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3371409</ArticleId><ArticleId IdType="pubmed">22661231</ArticleId></ArticleIdList></Reference><Reference><Citation>Braunschweig U, Barbosa-Morais NL, Pan Q, et al.Widespread intron retention in mammals functionally tunes transcriptomes. Genome Res. 2014;24:1774&#x2013;1786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4216919</ArticleId><ArticleId IdType="pubmed">25258385</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutz PL, Bhutkar A, Sharp PA.. Detained introns are a novel, widespread class of post-transcriptionally spliced introns. Genes Dev. 2015;29:63&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4281565</ArticleId><ArticleId IdType="pubmed">25561496</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauger O, Lemoine F, Scheiffele P.. Targeted intron retention and excision for rapid gene regulation in response to neuronal activity. Neuron. 2016;92:1266&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pubmed">28009274</ArticleId></ArticleIdList></Reference><Reference><Citation>Luisier R, Tyzack GE, Hall CE, et al.Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat Commun. 2018;9:2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5964114</ArticleId><ArticleId IdType="pubmed">29789581</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley PT, Lee MT, Sul J-Y, et al.Cytoplasmic intron sequence-retaining transcripts can be dendritically targeted via ID element retrotransposons. Neuron. 2011;69:877&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3065018</ArticleId><ArticleId IdType="pubmed">21382548</ArticleId></ArticleIdList></Reference><Reference><Citation>Colak D, Ji S-J, Porse BT, Jaffrey SR.. Regulation of axon guidance by compartmentalized nonsense-mediated mRNA decay. Cell. 2013;153:1252&#x2013;1265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3685487</ArticleId><ArticleId IdType="pubmed">23746841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong JJ-L, Ritchie W, Ebner OA, et al.Orchestrated intron retention regulates normal granulocyte differentiation. Cell. 2013;154:583&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pubmed">23911323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilchert C, Wittmann S, Passoni M, Shah S, Granneman S, Vasiljeva L.. Regulation of mRNA levels by decay-promoting introns that recruit the exosome specificity factor Mmi1. Cell Rep. 2015;13:2504&#x2013;2515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4695336</ArticleId><ArticleId IdType="pubmed">26670050</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaladkar M, Buckley PT, Lee MT, et al.Subcellular RNA sequencing reveals broad presence of cytoplasmic intron-sequence retaining transcripts in mouse and rat neurons. PLoS One. 2013;8:e76194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3789819</ArticleId><ArticleId IdType="pubmed">24098440</ArticleId></ArticleIdList></Reference><Reference><Citation>Price AJ, Hwang T, Tao R, et al.Characterizing the nuclear and cytoplasmic transcriptomes in developing and mature human cortex uncovers new insight into psychiatric disease gene regulation. Genome Res. 2020;30:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6961577</ArticleId><ArticleId IdType="pubmed">31852722</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini H, Bicknell AA, Eddy SR, Moore MJ.. Free circular introns with an unusual branchpoint in neuronal projections [Internet]. Elife. 2019;8:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6879206</ArticleId><ArticleId IdType="pubmed">31697236</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharangdhar T, Sugimoto Y, Heraud&#x2010;Farlow J, et al.A retained intron in the 3&#x2032;&#x2010; UTR of Calm3 mRNA mediates its Staufen2&#x2010; and activity&#x2010;dependent localization to neuronal dendrites. EMBO Rep. 2017;18:1762&#x2013;1774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5623867</ArticleId><ArticleId IdType="pubmed">28765142</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al.Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack GE, Luisier R, Taha DM, et al.Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain. 2019;142:2572&#x2013;2580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, et al.TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortobagyi T, et al.Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall CE, Yao Z, Choi M, et al.Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS. Cell Rep. 2017;19:1739&#x2013;1749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Irimia M, Weatheritt RJ, Ellis JD, et al.A highly conserved program of neuronal microexons is misregulated in autistic brains. Cell. 2014;159:1511&#x2013;1523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4390143</ArticleId><ArticleId IdType="pubmed">25525873</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K, Pratt GA, Vu AQ, et al.Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat Commun. 2016;7:12143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4935974</ArticleId><ArticleId IdType="pubmed">27378374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, Sandoe J, Williams LA, et al.Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014;14:781&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Galante PAF, Sakabe NJ, Kirschbaum-Slager N, de Souza SJ.. Detection and evaluation of intron retention events in the human transcriptome. RNA. 2004;10:757&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1370565</ArticleId><ArticleId IdType="pubmed">15100430</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakabe NJ, de Souza SJ.. Sequence features responsible for intron retention in human. BMC Genomics. 2007;8:59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1831480</ArticleId><ArticleId IdType="pubmed">17324281</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Morris JH, Cook H, et al.The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45:D362&#x2013;D368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210637</ArticleId><ArticleId IdType="pubmed">27924014</ArticleId></ArticleIdList></Reference><Reference><Citation>Croft D, Mundo AF, Haw R, et al.The Reactome pathway knowledgebase. Nucleic Acids Res. 2014;42:D472&#x2013;D477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3965010</ArticleId><ArticleId IdType="pubmed">24243840</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan CA, Chan ET, Davidson JM, et al.ENCODE data at the ENCODE portal. Nucleic Acids Res. 2016;44:D726&#x2013;D732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702836</ArticleId><ArticleId IdType="pubmed">26527727</ArticleId></ArticleIdList></Reference><Reference><Citation>A large-scale binding and functional map of human RNA binding proteins [Internet]. Nature 2020;583: 711&#x2013;719. 10.1038/s41586-020-2077-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2077-3</ArticleId><ArticleId IdType="pmc">PMC7410833</ArticleId><ArticleId IdType="pubmed">32728246</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley J, Hagemann C, Serio A, Patani R.. FUS is lost from nuclei and gained in neurites of motor neurons in a human stem cell model of VCP-related ALS. Brain. 2020;143:e103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7805784</ArticleId><ArticleId IdType="pubmed">33253377</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley J, Patani R.. Stress-specific spatiotemporal responses of RNA-binding proteins in human stem-cell-derived motor neurons [Internet]. Int J Mol Sci. 2020;21:21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664327</ArticleId><ArticleId IdType="pubmed">33172210</ArticleId></ArticleIdList></Reference><Reference><Citation>Pervouchine D, Popov Y, Berry A, Borsari B, Frankish A, Guig&#xf3; R.. Integrative transcriptomic analysis suggests new autoregulatory splicing events coupled with nonsense-mediated mRNA decay. Nucleic Acids Res. 2019;47:5293&#x2013;5306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6547761</ArticleId><ArticleId IdType="pubmed">30916337</ArticleId></ArticleIdList></Reference><Reference><Citation>Stagsted LVW, O&#x2019;Leary ET, Hansen TB. The RNA-binding protein SFPQ preserves long-intron splicing and regulates circRNA biogenesis. Elife. 2021;10:e63088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7819710</ArticleId><ArticleId IdType="pubmed">33476259</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan AL, Grima N, Fifita JA, et al. SFPQ intron retention, reduced expression and aggregate formation in central nervous system tissue are pathological features of amyotrophic lateral sclerosis. bioRxiv. [Preprint] doi:10.1101/2020.09.22.309062</Citation><ArticleIdList><ArticleId IdType="pubmed">34288034</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun CJ, Stanciu M, Boutz PL, et al.Coordinated splicing of regulatory detained introns within oncogenic transcripts creates an exploitable vulnerability in malignant glioma. Cancer Cell. 2017;32:411&#x2013;426.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5929990</ArticleId><ArticleId IdType="pubmed">28966034</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt CE, Bullock SL.. Subcellular mRNA localization in animal cells and why it matters. Science. 2009;326:1212&#x2013;1216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785123</ArticleId><ArticleId IdType="pubmed">19965463</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>